Literature DB >> 6169666

Block of glioma cell line in S by interferon.

D Lundblad, E Lundgren.   

Abstract

The human glioma cell line U-251 MG, with a well-characterized defect in growth control, was sensitive to the antiproliferative effects of human (fibroblast) interferon (IFN). IFN inhibited exponentially growing cells by increasing the number of cells in the S stage of the cell cycle. At the same time the number of cells in Go/G1 diminished. The rate of thymidine incorporation was decreased during the first cell cycle, with no prolongation of S. However, in synchronized cultures, the wave of cells with a S-phase content did not decrease over a time period several hours longer than the length of S measured by pulse labelling. Thus we conclude that, at a sufficient dose, the cells were unable to accomplish cell division as they prematurely stopped synthesizing DNA.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6169666     DOI: 10.1002/ijc.2910270604

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  Local immunotherapy (beta-IFN) and systemic chemotherapy in primary glial tumors.

Authors:  A Boiardi; A Silvani; I Milanesi; L Munari; G Broggi; M Botturi
Journal:  Ital J Neurol Sci       Date:  1991-04

Review 2.  Regulation of cell proliferation and differentiation by interferons.

Authors:  M J Clemens; M A McNurlan
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

Review 3.  Regulation of cell growth by interferon.

Authors:  M Shearer; J Taylor-Papadimitriou
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Interferon effects on multiplication, cytoplasmic protein and GFAP content, and morphology in human glioma cells.

Authors:  K Korosue; I Takeshita; H Mannoji; M Fukui
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

5.  Interferon-gamma enhances radiation-induced cell death via downregulation of Chk1.

Authors:  Kwang Seok Kim; Kyu Jin Choi; Sangwoo Bae
Journal:  Cancer Biol Ther       Date:  2012-07-24       Impact factor: 4.742

6.  Effects of interferon and PKC modulators on human glioma protein kinase C, cell proliferation, and cell cycle.

Authors:  M Acevedo-Duncan; R Zhang; D R Cooper; H M Greenberg
Journal:  Neurochem Res       Date:  1997-07       Impact factor: 3.996

7.  Inhibition of type I interferon-mediated antiviral action in human glioma cells by the IKK inhibitors BMS-345541 and TPCA-1.

Authors:  Ziyun Du; Michael A Whitt; Jessica Baumann; Jo Meagan Garner; Christopher L Morton; Andrew M Davidoff; Lawrence M Pfeffer
Journal:  J Interferon Cytokine Res       Date:  2012-04-17       Impact factor: 2.607

8.  IFN-beta gene therapy induces systemic antitumor immunity against malignant glioma.

Authors:  A Natsume; K Tsujimura; M Mizuno; T Takahashi; J Yoshida
Journal:  J Neurooncol       Date:  2000-04       Impact factor: 4.130

9.  Clinical effect of interferon in malignant brain tumours.

Authors:  M Nagai; T Arai
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

10.  Interferon effect on glycosaminoglycans in mouse glioma in vitro.

Authors:  M Wiranowska; A K Naidu
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.